NextRNA Therapeutics, Inc. is a MA-based newly founded biotechnology company committed to leading the next revolution of RNA-directed therapeutics. Based on the foundational work of Carl Novina at Dana-Farber Cancer Institute, NextRNA has established a proprietary target and drug discovery engine that enables us to systematically identify disease-relevant long non-coding RNAs and their interacting proteins, and develop selective small molecules to drug RNA-protein interactions. The company is currently advancing two small molecule therapeutic programs in oncology and immunology. NextRNA has assembled a highly experienced and competent team of industry leaders, biology and chemistry experts, and drug developers, all driven by a common passion for working together and having an impact on science and patients.
NextRNA Therapeutics Address
40 Guest St. Cambridge, MA
NextRNA Therapeutics Email
Past Companies
NextRNA TherapeuticsHead Of Platform Technology
Takeda OncologyHead of Discovery Analytical Chemistry Technology Group (Associate Director)
Takeda OncologyHead of Discovery Analytical Research Group (Senior Scientist 2)